Industry
Market for IHC Tests Growing in Europe
Immunohistochemistry (IHC) is emerging as an important tool for cancer diagnostics in Europe, following the development of new-generation diagnostic kits that can detect cancer at its earliest stages, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm. More...31 Mar 2006
.jpg)
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Hematology Consumables
Bioblood Devices
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
In Other News
Commercializing Protein Tomography Solutions
Microarray Products for Far East Market
Bayer Licenses Immunoassays to Signet Labs
BD to Acquire GeneOhm Sciences
AEI Acquires Norgren Systems
Two Firms Join to Develop Quick Flu Test
Control Plasma for vWF Testing
ARMS Technology License Extended
Qiagen Acquires Eppendorf's Reagent Business
Beta Device for Detecting Cervical Cancer
Olympus Moves Into Immunoassays
New Test for Staph Infections
Personalized Test for Cancer Drug
Innogenetics Acquires PCR License
Prenatal Diagnostic Technology Licensed
Alliance for Biomarker Validation Technologies
ExonHit and bioMerieux Extend Alliance
Collaboration to Develop Sepsis Diagnostics
Diagnostic Acquisitions Expand Inverness
Bayer Contracts for New Immunoassays
Bayer and CIS Biotech in Assay Alliance
Olympus Opens New Immunoassay Facility
Alliance to Develop Diagnostic Tests
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
